PMID- 20422032 OWN - NLM STAT- MEDLINE DCOM- 20110616 LR - 20211020 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 5 IP - 4 DP - 2010 Apr 20 TI - 20-HETE mediates ozone-induced, neutrophil-independent airway hyper-responsiveness in mice. PG - e10235 LID - 10.1371/journal.pone.0010235 [doi] LID - e10235 AB - BACKGROUND: Ozone, a pollutant known to induce airway hyper-responsiveness (AHR), increases morbidity and mortality in patients with obstructive airway diseases and asthma. We postulate oxidized lipids mediate in vivo ozone-induced AHR in murine airways. METHODOLOGY/PRINCIPAL FINDINGS: Male BALB/c mice were exposed to ozone (3 or 6 ppm) or filtered air (controls) for 2 h. Precision cut lung slices (PCLS; 250 microm thickness) containing an intrapulmonary airway ( approximately 0.01 mm(2) lumen area) were prepared immediately after exposure or 16 h later. After 24 h, airways were contracted to carbachol (CCh). Log EC(50) and E(max) values were then calculated by measuring the airway lumen area with respect to baseline. In parallel studies, dexamethasone (2.5 mg/kg), or 1-aminobenzotriazol (ABT) (50 mg/kg) were given intraperitoneal injection to naive mice 18 h prior to ozone exposure. Indomethacin (10 mg/kg) was administered 2 h prior. Cell counts, cytokine levels and liquid chromatography-mass spectrometry (LC-MS) for lipid analysis were assessed in bronchoalveolar lavage (BAL) fluid from ozone exposed and control mice. Ozone acutely induced AHR to CCh. Dexamethasone or indomethacin had little effect on the ozone-induced AHR; while, ABT, a cytochrome P450 inhibitor, markedly attenuated airway sensitivity. BAL fluid from ozone exposed animals, which did not contain an increase in neutrophils or interleukin (IL)-6 levels, increased airway sensitivity following in vitro incubation with a naive PCLS. In parallel, significant increases in oxidized lipids were also identified using LC-MS with increases of 20-HETE that were decreased following ABT treatment. CONCLUSIONS/SIGNIFICANCE: These data show that ozone acutely induces AHR to CCh independent of inflammation and is insensitive to steroid treatment or cyclooxygenase (COX) inhibition. BAL fluid from ozone exposed mice mimicked the effects of in vivo ozone exposure that were associated with marked increases in oxidized lipids. 20-HETE plays a pivotal role in mediating acute ozone-induced AHR. FAU - Cooper, Philip R AU - Cooper PR AD - Department of Medicine and the Airways Biology Initiative, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America. FAU - Mesaros, A Clementina AU - Mesaros AC FAU - Zhang, Jie AU - Zhang J FAU - Christmas, Peter AU - Christmas P FAU - Stark, Christopher M AU - Stark CM FAU - Douaidy, Karim AU - Douaidy K FAU - Mittelman, Michael A AU - Mittelman MA FAU - Soberman, Roy J AU - Soberman RJ FAU - Blair, Ian A AU - Blair IA FAU - Panettieri, Reynold A AU - Panettieri RA LA - eng GR - R01 DK074821/DK/NIDDK NIH HHS/United States GR - R01 AI-068871/AI/NIAID NIH HHS/United States GR - R01 RO1DK74821/DK/NIDDK NIH HHS/United States GR - P30 ES013508/ES/NIEHS NIH HHS/United States GR - R01 AI068871/AI/NIAID NIH HHS/United States GR - R01CA091016/CA/NCI NIH HHS/United States GR - P30ES013508/ES/NIEHS NIH HHS/United States GR - R01 CA091016/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20100420 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (Hydroxyeicosatetraenoic Acids) RN - 0 (Triazoles) RN - 1614-12-6 (1-aminobenzotriazole) RN - 66H7ZZK23N (Ozone) RN - 79551-86-3 (20-hydroxy-5,8,11,14-eicosatetraenoic acid) RN - 8Y164V895Y (Carbachol) SB - IM MH - Animals MH - Bronchial Hyperreactivity MH - Carbachol/pharmacology MH - Hydroxyeicosatetraenoic Acids/*analysis/*immunology MH - Lipid Peroxidation MH - Male MH - Mass Spectrometry MH - Mice MH - Mice, Inbred BALB C MH - Neutrophils MH - Ozone/*pharmacology MH - Respiratory Hypersensitivity/*etiology MH - Triazoles/pharmacology PMC - PMC2857875 COIS- Competing Interests: The authors have declared that no competing interests exist. EDAT- 2010/04/28 06:00 MHDA- 2011/06/17 06:00 PMCR- 2010/04/20 CRDT- 2010/04/28 06:00 PHST- 2009/12/16 00:00 [received] PHST- 2010/03/26 00:00 [accepted] PHST- 2010/04/28 06:00 [entrez] PHST- 2010/04/28 06:00 [pubmed] PHST- 2011/06/17 06:00 [medline] PHST- 2010/04/20 00:00 [pmc-release] AID - 09-PONE-RA-15016R1 [pii] AID - 10.1371/journal.pone.0010235 [doi] PST - epublish SO - PLoS One. 2010 Apr 20;5(4):e10235. doi: 10.1371/journal.pone.0010235.